ciltacabtagene autoleucel,idecabtagene vicleucel
2seventy bio,bms,janssen
['mmsm', 'ide cel', 'cilta cel']
3/4 of pts on re mm car-t cohort (ide cel, cilta cel) would not met trial eligibility due to stringent criteria #mmsm #asco2023 
Multiple Myeloma Specialist  at UTSW Harold C. Simmons Comprehensive Cancer Center | Montefiore  & Tufts Alum